1104 related articles for article (PubMed ID: 12666217)
21. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.
Zosmer N; Souter VL; Chan CS; Huggon IC; Nicolaides KH
Br J Obstet Gynaecol; 1999 Aug; 106(8):829-33. PubMed ID: 10453834
[TBL] [Abstract][Full Text] [Related]
22. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
23. Ductus venosus blood flow in chromosomally abnormal fetuses at 11 to 14 weeks of gestation.
Matias A; Montenegro N
Semin Perinatol; 2001 Feb; 25(1):32-7. PubMed ID: 11254158
[TBL] [Abstract][Full Text] [Related]
24. Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications.
Maiz N; Nicolaides KH
Fetal Diagn Ther; 2010; 28(2):65-71. PubMed ID: 20571255
[TBL] [Abstract][Full Text] [Related]
25. Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy.
Borrell A; Martinez JM; Serés A; Borobio V; Cararach V; Fortuny A
Prenat Diagn; 2003 Nov; 23(11):921-6. PubMed ID: 14634979
[TBL] [Abstract][Full Text] [Related]
26. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
Maiz N; Valencia C; Emmanuel EE; Staboulidou I; Nicolaides KH
Obstet Gynecol; 2008 Sep; 112(3):598-605. PubMed ID: 18757658
[TBL] [Abstract][Full Text] [Related]
27. The evaluation of cardiac biometry in major cardiac defects detected in early pregnancy.
Smrcek JM; Gembruch U; Krokowski M; Berg C; Krapp M; Geipel A; Germer U
Arch Gynecol Obstet; 2003 Jun; 268(2):94-101. PubMed ID: 12768297
[TBL] [Abstract][Full Text] [Related]
28. Umbilical cord diameter at 11-14 weeks of gestation: relationship to nuchal translucency, ductus venous blood flow and chromosomal defects.
Axt-Fliedner R; Schwarze A; Kreiselmaier P; Krapp M; Smrcek J; Diedrich K
Fetal Diagn Ther; 2006; 21(4):390-5. PubMed ID: 16757918
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional cardiac abnormalities identified prior to 16 weeks' gestation in fetuses with increased nuchal translucency.
Lopes LM; Brizot ML; Lopes MA; Ayello VD; Schultz R; Zugaib M
Ultrasound Obstet Gynecol; 2003 Nov; 22(5):470-8. PubMed ID: 14618659
[TBL] [Abstract][Full Text] [Related]
30. Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects.
Chelemen T; Syngelaki A; Maiz N; Allan L; Nicolaides KH
Fetal Diagn Ther; 2011; 29(2):127-34. PubMed ID: 21160164
[TBL] [Abstract][Full Text] [Related]
31. Is the addition of the ductus venosus useful when screening for aneuploidy and congenital heart disease in fetuses with normal nuchal translucency?
Prats P; Ferrer Q; Comas C; Rodríguez I
Fetal Diagn Ther; 2012; 32(1-2):138-43. PubMed ID: 22585666
[TBL] [Abstract][Full Text] [Related]
32. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome.
Toyama JM; Brizot ML; Liao AW; Lopes LM; Nomura RM; Saldanha FA; Zugaib M
Ultrasound Obstet Gynecol; 2004 Apr; 23(4):341-5. PubMed ID: 15065182
[TBL] [Abstract][Full Text] [Related]
33. Screening performances of abnormal first-trimester ductus venosus blood flow and increased nuchal translucency thickness in detection of major heart defects.
Karadzov-Orlic N; Egic A; Filimonovic D; Damnjanovic-Pazin B; Milovanovic Z; Lukic R; Mandic V; Joksic I; Vukomanovic V; Kosutic J; Djuricic S; Mikovic Z
Prenat Diagn; 2015 Dec; 35(13):1308-15. PubMed ID: 26408089
[TBL] [Abstract][Full Text] [Related]
34. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
[TBL] [Abstract][Full Text] [Related]
35. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
[TBL] [Abstract][Full Text] [Related]
36. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
[TBL] [Abstract][Full Text] [Related]
37. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
38. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
[TBL] [Abstract][Full Text] [Related]
39. Ductus venosus blood flow resistance and congenital heart defects in the second trimester.
Hung JH; Fu CY; Lu JH; Hung CY
J Clin Ultrasound; 2008 Feb; 36(2):72-8. PubMed ID: 17676619
[TBL] [Abstract][Full Text] [Related]
40. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
